Home - Products - Others - Other Targets - Atrial Natriuretic Peptide (126-149) (rat)

Atrial Natriuretic Peptide (126-149) (rat)

CAS No. 91421-87-3

Atrial Natriuretic Peptide (126-149) (rat)( ——— )

Catalog No. M41407 CAS No. 91421-87-3

Auriculin A is a synthetic atrial?natriuretic?factor?(ANF) with hemodynamic effect. Auriculin A antagonizes renal vasoconstriction in the dog, and influences on arterial baroreflex control of heart rate, systemic blood pressure, and perfusion pressure in the hind limb (perfused at constant flow) in rabbits.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote

Biological Information

  • Product Name
    Atrial Natriuretic Peptide (126-149) (rat)
  • Note
    Research use only, not for human use.
  • Brief Description
    Auriculin A is a synthetic atrial?natriuretic?factor?(ANF) with hemodynamic effect. Auriculin A antagonizes renal vasoconstriction in the dog, and influences on arterial baroreflex control of heart rate, systemic blood pressure, and perfusion pressure in the hind limb (perfused at constant flow) in rabbits.
  • Description
    Auriculin A is a synthetic atrial?natriuretic?factor?(ANF) with hemodynamic effect. Auriculin A antagonizes renal vasoconstriction in the dog, and influences on arterial baroreflex control of heart rate, systemic blood pressure, and perfusion pressure in the hind limb (perfused at constant flow) in rabbits.
  • In Vitro
    ———
  • In Vivo
    Auriculin A (0.3 μg/min/kg; i.v.; for 30 min) antagonizes renal vasoconstriction in the dog.Auriculin A (2 μg/kg prime, 0.2 μg/kg/min; i.v.; for 45 min) influences on arterial baroreflex control of heart rate, systemic blood pressure, and perfusion pressure in the hind limb (perfused at constant flow) in rabbits.Animal Model:Female mongrel dogs used in early clamp experiments (15-20 kg, anesthetized with 30 mg/kg pentobarbital sodium i.v.)Dosage:0.3 μg/min/kg Administration:Intravenous injection; last for 30 min Result:Increased glomerular filtration rate (GFR) 16±4% and Na excretion (UNa V) 261±63%, whereas it decreased urine osmolality (Uosm) 36±7% without changing free water clearance. Also increased diuresis (V) and kaliuresis (UKV). Animal Model:New Zealand white male rabbits (3-3.5 kg, anesthetized with 50 mg/kg Chloralose and 500 mg/kg Urethane i.v.)Dosage:0.5 μg/kg prime, 0.05 μg/kg/min; 2 μg/kg prime, 0.2 μg/kg/min; 4 μg/kg prime, 0.4 μg/kg/min; 8 μg/kg prime, 0.8 μg/kg/min Administration:Intravenous injection; last for 30-60 min Result:Significantly reduced mean blood pressure and increased mean perfusion pressure at 4 μg/kg prime, 0.4 μg/kg/min dose, while heart rate did not change.
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    91421-87-3
  • Formula Weight
    2542.86
  • Molecular Formula
    C104H168N38O33S2
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sosa RE, et al. Relationship between renal hemodynamic and natriuretic effects of atrial natriuretic factor. Am J Physiol. 1986 Mar;250(3 Pt 2):F520-4.?
molnova catalog
related products
  • Reynoutrin

    Reynoutrin with antioxidant and radical-scavenging activity.

  • Milbemycin oxime

    Milbemycin oxime is a veterinary drug from the group of milbemycins, used as a broad spectrum antiparasitic.

  • Corey Lactone Diol

    Corey Lactone Diol is a pharmaceutical intermediate.